Table 1 The inhibitory effect of peptides on H1N1 influenza A virus and toxicity on MDCK cells.

From: A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities

Name

Sequence a

MW b

IC50 ± SD c (μM)

CC50 ± SD d (μM)

SI e

18-Jp

C18-ARLPR

878.03

1.44 ± 0.11* ,g

114.33 ± 1.46

102.72

20-Hp

C20-KKWK

883.28

4.17 ± 0.04**

60.23 ± 0.74

14.41

Rirbavirin

NA f

244.21

12.85 ± 0.08**

NT

NA f

C16-Hp-Jp

C16-KKWKARLPR

1420.90

2.48 ± 0.24

>200

NA

C18-Hp-Jp

C18-KKWKARLPR

1448.76

0.75 ± 0.18

135.52 ± 1.29

178.49

C20-Hp-Jp

C20-KKWKARLPR

1477.01

0.71 ± 0.37

129.19 ± 3.85

180.01

C16-Jp-Hp

C16-ARLPRKKWK

1420.90

1.29 ± 0.40

>200

NA

C18-Jp-Hp

C18-ARLPRKKWK

1448.76

0.61 ± 0.04

139.59 ± 0.64

227.23

C20-Jp-Hp

C20-ARLPRKKWK

1477.01

0.53 ± 0.25

135.34 ± 0.58

253.03

C16-Hp-GGG-Jp

C16-KKWKGGGARLPR

1592.06

8.05 ± 0.52**

>200

NA

C18-Hp-GGG-Jp

C18-KKWKGGGARLPR

1619.92

6.99 ± 2.00**

>200

NA

C20-Hp-GGG-Jp

C20-KKWKGGGARLPR

1932.45

5.22 ± 0.37**

>200

NA

C16-Jp-GGG-Hp

C16-ARLPRGGGKKWK

1592.06

6.79 ± 0.17**

>200

NA

C18-Jp-GGG-Hp

C18-ARLPRGGGKKWK

1619.92

5.09 ± 0.35**

>200

NA

C20-Jp-GGG-Hp

C20-ARLPRGGGKKWK

1932.45

4.04 ± 0.02*

>200

NA

C20-ALLSA-Hp

C20-ALLSAKKWK

1338.84

1.69 ± 1.38*

>200

NA

C20-Hp-ALLSA

C20-KKWKALLSA

1338.84

3.80 ± 2.88*

>200

NA

  1. aAll C-termini were amidated;
  2. bthe molecular weight calculation was based on: http://www.peptidesynthetics.co.uk/tools/ ;
  3. cThe activity was tested with CPE assay toward influenza virus of A/Puerto Rico/8/34 (H1N1);
  4. dThe data was acquired with MTT assay against MDCK cells;
  5. eSI: selectivity index;
  6. fNT: not tested. NA: not available.
  7. g,*Statistical significance was determined by one-way ANOVA method using SPSS 20.0 software. Values denote means with SD in five independent repeats. Statistical significance of the data with C20-Jp-Hp was defined as p < 0.05 (*p < 0.05, **p < 0.01, using ANOVA with Bonferroni test).